TrialEsophagus : official journal of the Japan Esophageal Society2022

A phase II study of S-1 therapy for patients with advanced and recurrent esophageal cancer resistant or intolerable to fluorouracil, platinum, and taxane therapy (OGSG 1404).

Motoo Nomura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.